In order to clarify the effect of HRG1 and HER-3 on HER dimerization, we evaluated in breast cancer cell lines the dimer formation pattern after the addition of trastuzumab, pertuzumab and their combination with or without HRG1. This evidence concerns the gene ERBB3 and breast cancer.